These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 27564665

  • 21. Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.
    Strange C.
    Respir Care; 2018 Jun; 63(6):690-698. PubMed ID: 29794204
    [Abstract] [Full Text] [Related]

  • 22. α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency.
    Bazzan E, Tinè M, Biondini D, Benetti R, Baraldo S, Turato G, Fagiuoli S, Sonzogni A, Rigobello C, Rea F, Calabrese F, Foschino-Barbaro MP, Miranda E, Lomas DA, Saetta M, Cosio MG.
    Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
    [Abstract] [Full Text] [Related]

  • 23. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF, Miravitlles M.
    Respir Res; 2017 May 30; 18(1):105. PubMed ID: 28558837
    [Abstract] [Full Text] [Related]

  • 24. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM, Louie SG.
    Expert Opin Pharmacother; 2007 Oct 30; 8(15):2609-14. PubMed ID: 17931094
    [Abstract] [Full Text] [Related]

  • 25. Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.
    Bashir A, Shah NN, Hazari YM, Habib M, Bashir S, Hilal N, Banday M, Asrafuzzaman S, Fazili KM.
    Respir Med; 2016 Aug 30; 117():139-49. PubMed ID: 27492524
    [Abstract] [Full Text] [Related]

  • 26. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.
    Greene CM, Hassan T, Molloy K, McElvaney NG.
    Expert Rev Respir Med; 2011 Jun 30; 5(3):395-411. PubMed ID: 21702661
    [Abstract] [Full Text] [Related]

  • 27. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency.
    Brand P, Schulte M, Wencker M, Herpich CH, Klein G, Hanna K, Meyer T.
    Eur Respir J; 2009 Aug 30; 34(2):354-60. PubMed ID: 19251783
    [Abstract] [Full Text] [Related]

  • 28. Alpha 1-antitrypsin deficiency: an overview.
    van Steenbergen W.
    Acta Clin Belg; 1993 Aug 30; 48(3):171-89. PubMed ID: 8396299
    [Abstract] [Full Text] [Related]

  • 29. Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individuals.
    McCarthy C, Saldova R, O'Brien ME, Bergin DA, Carroll TP, Keenan J, Meleady P, Henry M, Clynes M, Rudd PM, Reeves EP, McElvaney NG.
    J Proteome Res; 2014 Feb 07; 13(2):596-605. PubMed ID: 24328305
    [Abstract] [Full Text] [Related]

  • 30. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA.
    Am J Respir Crit Care Med; 1999 Dec 07; 160(6):1968-75. PubMed ID: 10588615
    [Abstract] [Full Text] [Related]

  • 31. Augmentation therapy with alpha1-antitrypsin: novel perspectives.
    Sabina J, Tobias W.
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug 07; 13(2):90-8. PubMed ID: 23987997
    [Abstract] [Full Text] [Related]

  • 32. Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD.
    Li L, Kueppers F, Hildebrand W, Buchli R, Gaughan J.
    Exp Lung Res; 2012 Aug 07; 38(6):302-6. PubMed ID: 22686467
    [Abstract] [Full Text] [Related]

  • 33. [Proteases, antiproteases and pulmonary emphysema].
    Pelletier A, Pauli G, Bieth JG.
    Rev Fr Mal Respir; 1982 Aug 07; 10(6):369-89. PubMed ID: 6187052
    [Abstract] [Full Text] [Related]

  • 34. A review of alpha-1 antitrypsin deficiency.
    Ioachimescu OC, Stoller JK.
    COPD; 2005 Jun 07; 2(2):263-75. PubMed ID: 17136953
    [Abstract] [Full Text] [Related]

  • 35. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA, Brand T, Gardi C, van Even P, de Santi MM, Calzoni P, Marcolongo P, Lungarella G.
    Lab Invest; 1993 Feb 07; 68(2):233-41. PubMed ID: 8441253
    [Abstract] [Full Text] [Related]

  • 36. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
    Krotova K, Marek GW, Wang RL, Aslanidi G, Hoffman BE, Khodayari N, Rouhani FN, Brantly ML.
    Am J Respir Cell Mol Biol; 2017 Aug 07; 57(2):238-247. PubMed ID: 28362108
    [Abstract] [Full Text] [Related]

  • 37. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
    Piitulainen E, Carlson J, Ohlsson K, Sveger T.
    Chest; 2005 Oct 07; 128(4):2076-81. PubMed ID: 16236857
    [Abstract] [Full Text] [Related]

  • 38. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG.
    Ann Am Thorac Soc; 2016 Apr 07; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [Abstract] [Full Text] [Related]

  • 39. Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro?
    Persson C, Subramaniyam D, Stevens T, Janciauskiene S.
    Chest; 2006 Jun 07; 129(6):1683-92. PubMed ID: 16778290
    [Abstract] [Full Text] [Related]

  • 40. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
    Sosulski ML, Stiles KM, Frenk EZ, Hart FM, Matsumura Y, De BP, Kaminsky SM, Crystal RG.
    JCI Insight; 2020 Aug 06; 5(15):. PubMed ID: 32759494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.